Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral meniere's disease

Laryngoscope

Volumn 120, Issue 1, 2010, Pages 103-107

  Lopez Escamez, Jose A ^a   Saenz Lopez, Pablo ^b   Acosta, Lourdes ^a   Moreno, Antonia ^b   Gazquez, Irene ^a   Perez Garrigues, Herminio ^c   Lopez Nevot, Alicia ^b   Lopez Nevot, Miguel A ^b  

^a HOSPITAL DE PONIENTE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Autoimmunity; CTLA4 gene; Meniere's disease; PTPN22 gene; Vestibular system

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN TYROSINE PHOSPHATASE;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MIDDLE AGED;

AUTOIMMUNITY; FEMALE; GENOTYPE; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASES; SPAIN;

EID: 74049157115     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20650     Document Type: Article

References (23)

1. Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA. Meniere's disease: an immune complex-mediated illness? Laryngoscope 1991;101:225-229.
2. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 1995;105:1347-1352.
3. Brooks GB. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 1986;112: 536-540.
4. Ruckenstein MJ, Prasthoffer A, Bieglow DC, Von Feldt JM, Kolasinski SL. Immunologic and serologic testing in patients with Ménière's disease. Otol Neurotol 2002;23: 517-521.
5. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-511.
6. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002;12:3-6.
7. Torres B, Aguilar F, Franco E, et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 2004;50:2211-2215.
8. Blomhoff A, Lie BA, Myhre AG, et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 2004;89:3474-3476.
9. Donner H, Rau H, Walfish PG, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type I diabetes mellitus. J Clin Endocrinol Metab 1997;82: 143-146.
10. Mustelin T, Alonso A, Bottinit N, et al. Protein tyrosine phosphatases in T cell physiology. Mol Immunol 2004;41: 687-700.
11. Begovich AB, Carlton VEH, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75: 330-337.
12. Siminovitch KA. PTPN22 and autoimmunity disease. Nat Genet 2004;36:1248-1249.
13. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-338.
14. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005;7:1-15.
15. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113: 181-185.
16. Orozco G, Gonzalez-Gay MA, Lopez-Nevot MA, et al. Association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005;52:219-224.
17. Suslu N, Yilmaz T, Gursel B. Utility of immunologic parameters in the evaluation of Meniere's disease. Acta Otolaryngol 2009;13:1-6.
18. Chikuma S, Imboden J, Bluestone JA. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen U. J Exp Med 2003;197: 129-135.
19. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 2000;1:170-184.
20. LaBerge GS, Bennett DC, Fain PR, Spritx RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 2008;128:1757-1762.
21. Orozco G, Torres B, Nunez-Roldan A, Gonzalez-Escribano MF, Martin J. Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis. Tissue Antigens 2004;64:667-670.
22. Rueda B, Zhernakova A, Lopez-Nevot MA, et al. CTLA4/ CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders. Hum Immunol 2005;66:321-325.
23. Lopez-Escamez JA, Viciana D, Garrido-Fernandez P. Impact of bilaterality and headache on health-related quality of life in Meniere's disease. Ann Otol Rhinol Laryngol 2009; 118:409-416.